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Edited by Judit Ova´diAbstract The aim of this study was to determine if endothelin
converting enzyme-1 (ECE-1) like other members of this metal-
loprotease family undergoes ectodomain shedding. The release/
shedding of catalytically active ECE-1 was measured by moni-
toring the ﬂuorescence resulting from the cleavage of a speciﬁc
quenched ﬂuorescent substrate. Catalytically active ECE-1 was
detected in the media of human umbilical vein endothelial cells,
and was conﬁrmed by mass spectrometry based assays. Speciﬁc-
ity of cleavage was conﬁrmed by using both narrow and broad
speciﬁcity inhibitors. In conclusion we demonstrate and charac-
terize for the ﬁrst time, ECE-1 shedding from the surface of
endothelial cells.
 2007 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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Since its discovery over 15 years ago, endothelin (ET) has
attracted considerable scientiﬁc and clinical interest, reﬂecting
its extremely potent vasoconstrictor eﬀects [1]. ET is stored in
an inactive form (BigET-1) and upon secretion is cleaved by a
highly speciﬁc metallopeptidase called endothelin converting
enzyme-1 (ECE-1) to liberate the 21 amino acid bioactive ET
[2]. ECE-1 is a type II integral membrane metalloprotease with
a zinc co-ordinating motif and the protease is expressed pri-
marily on the plasma membrane of vascular endothelial cells.
ECE-1 is highly speciﬁc and cleaves its substrate (BigET-1)
between Trp21 and Val/Ile22. However, ECE-1 also cleaves
bradykinin in vitro [3], which may indicate additional natural
substrates for the enzyme.
Many cellular membrane proteins including enzymes are
known to be cleaved by proteases to release the extracellular,Abbreviations: ET-1, endothelin-1; ECE-1, endothelin converting
enzyme-1; ACE-2, angiotensin converting enzyme-2; MMP, matrix
metalloproteinase; ADAM, a distintegrin and metalloproteinases;
PKC, protein kinase C; HUVEC, human umbilical vein endothelial
cells; TIMP, tissue inhibitors of metalloproteinase; NEP, neutral
endopeptidase; QFS, quenched ﬂuorescent substrate; PMA, phorbol
12-myristate 13-acetate
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shedding’ [4]. This process can release growth factors, cyto-
kines and other mediators from their membrane-bound pre-
cursors or result in the down-regulation of membrane-bound
receptors [5]. This is therefore an important mechanism that
regulates many physiological and pathophysiological events
such as cell growth [6] and disease processes [6,7]. Recent stud-
ies from our and other laboratories have shown that the cata-
lytically active ectodomain of angiotensin converting enzyme-2
(ACE2), a metallopeptidase related to ECE-1, is also shed
from the cell surface in vitro [4,8] and that this process is fur-
ther stimulated by the activation of protein kinase C (PKC) by
phorbol 12-myristate 13-acetate (PMA) [4].
Many of the ectodomain cleavage events are mediated by
Ca2+/Zn2+ dependent endoproteases, matrix metalloprotein-
ases (MMPs) and the closely related Zn-dependent ‘A disinte-
grin and metalloproteinases (ADAMs)’ [5,7,9–11]. The current
understanding of the function of this family of metalloprotein-
ases in ectodomain shedding is based on studies of ADAM-10
and ADAM-17. However, the contribution of other ADAMs
is increasingly evident [5]. ADAM-17 also referred to as tu-
mour necrosis factor-a converting enzyme (TACE) was the
ﬁrst sheddase to be isolated with a known physiological sub-
strate. TACE is implicated in the release of L-selection [12],
b-APP [13] and EGF receptor ligands [14] as well as ACE2 [4].
We hypothesized that the ectodomain of ECE-1 can also be
released into the extracellular mileu by a regulated cleavage
event. Proteolytic shedding of ECE-1 was measured by moni-
toring the cleavage of quenched ﬂuorescent substrate (QFS) in
conditioned media. A mass spectrometry approach involving
BigET18–34, was used to conﬁrm for the ﬁrst time that ECE-
1, endogenously expressed by human umbilical vein endothe-
lial cells undergoes ectodomain shedding. Our data also sug-
gest that ADAM family of metalloproteinases or MMPs are
not involved in the ECE-1 ectodomain cleavage.2. Methods
2.1. Cell culture
Human umbilical vein endothelial cells (HUVECs) were maintained
in Dulbecco’s modiﬁed Eagle’s medium supplemented with 8% (v/v)
fetal bovine serum, 1% penicillin/streptomycin/glutamine and HAT
supplement (1 vial/500 mL of media; Sigma), as mentioned previously
[15].
2.2. Preparation of cell membranes
Conﬂuent cells were washed twice with phosphate buﬀered saline
and scrapped from petri dishes into 50 mM HEPES containing
20 mM CaCl2 (pH 7.4). Cells were lysed by sonication using a Soniferation of European Biochemical Societies.
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4 C. The resulting pellet was resuspended and mixed for 2 h at 4 C
in ECE-1 assay buﬀer (50 mM Tris–HCl in 150 mM NaCl; pH 6.3)
containing 1% Triton X-100. Suspension was centrifuged for 1 min
at 15000 rpm and the supernatant was diluted 50-fold and stored at
4 C until used. All cell membrane protein preparations were used
within 48 h.
2.3. Secretion of soluble ECE-1
Conﬂuent cells were washed twice with phosphate buﬀered saline,
prior to incubating with serum free medium (OPTI-mem, Invitrogen)
for 4 h. The media was harvested and concentrated 10-fold using Ami-
con centrifugal ﬁlter devices (MWCO 30000 Da), and stored at 4 C
until analysed for ECE-1 activity within 48 h. HUVECs incubated in
serum free medium for 4 h containing either no addition or one of
the following reagents: GM 6001 (50 lM), TAPI-1 (3 lM), TIMP-1
(5 nM), TIMP-3 (5 nM) and PMA (1 lM) was used to study the eﬀect
of tissue inhibitors of metalloproteinases (TIMPs) or PKC stimulation,
on ECE-1 ectodomain cleavage.
2.4. ECE assays
ECE-1 activity of the cell membrane preparation or conditioned
media was determined by one of the following assays.
2.4.1. Quenched ﬂuorescent substrate activity assay. The ECE-1
activity of the conditioned media and cell membranes were determined
based on the ability to cleave the QFS (7-methoxy-coumarin-4-yl)ace-
tyl-Arg-Pro-Pro-Gly-Phe-Ser-Ala-Phe-Lys(2,4-dinitrophenyl) (QFS;
40 lM) and hence generate ﬂuorescence (custom synthesized by Aus-
pep; [16]). Fifteen microliters of concentrated media or diluted cell
membrane preparation was used in all experiments. Speciﬁcity was
conﬁrmed by the use of inhibitors thiorphan (10 lM) and phosphora-
midon (100 lM). Fluorescence measurements were recorded every
minute using an excitation wavelength of 320 nM and an emission
wavelength of 405 nM.
2.4.2. BigET and BigET18–34 assay. Conditioned media from HU-
VECs (60 lL) was added to the speciﬁc substrate BigET18–34; (MW
1907 Da; DIIWVNTPEHVVPYGLG; Auspep, Vic, Australia), or the
natural substrate BigET (MW 4283 Da) giving a ﬁnal concentration
of 33 or 66 lg/mL, respectively, in ECE-1 assay buﬀer. The reaction
mixture was incubated at 37 C. Fifty microliters aliquots were taken
at the following time points: 0 min, 1, 2 and 5 h. The reaction was
immediately terminated by adding 200 lL of 1% TFA in methanol.
After centrifugation (eppendorf microfuge; 15000 rpm) for 10 min the
supernatant was removed and the samples were dried (Speed-Vac,
Savant) and stored at 20 C until analysed by mass spectrometry.
2.5. Mass spectrometry and nano-LC – MSMS
Dried samples were reconstituted in 20 lL of 0.1% TFA, and 1 lL
was subjected to nano-LC (Ultimate 3000, Dionex). The column
(C18 PepMap100, 3 lm, 100 A˚ from LC Packings) was eluted at a ﬂow
rate of 0.3 lL/min using a gradient of 3–100% over 30 min, where sol-
vent A was 0.1% TFA and solvent B 80% ACN in 0.1% TFA. The col-
umn eﬄuent was monitored at 214 nm and the fractions were spotted
onto a 4700 target plate (Applied Biosystems) along with 0.3 lL of ma-
trix (a-cyano-4-hydroxycinnamic acid; 2 mg/mL in 50% ACN in 0.1%
TFA). The 4700 target plate was loaded into the 4700 Proteomics ToF
ToF analyzer (Applied Biosystems) and the samples ionized and run in
positive reﬂector mode. MS and MS/MS spectra were gathered and
analysed using Data Explorer software.
2.6. Data analysis
Rate of cleavage of QFS was calculated over 1 h and expressed as
Units of Fluorescence/min. Where indicated, one-way or two-way AN-
OVA followed by Bonforroni post hoc was used to compare data
(Prism Version 4.0, Graph Pad software), and P < 0.05 was considered
signiﬁcant.3. Results
3.1. Quenched ﬂuorescent substrate (QFS) activity assay
The ECE-1 like activity of the membranes and conditioned
media from HUVECs was measured based on their ability tocleave QFS, and hence generate ﬂuorescence. Speciﬁcity of
QFS cleavage was determined by measuring activity in the
presence of a speciﬁc inhibitor of neutral endopeptidase en-
zyme (NEP) thiorphan, and the dual NEP and ECE-1 inhibi-
tor phosphoramidon. The latter caused a signiﬁcant decrease
in the rate of ﬂuorescence induced by, the cell membranes
and conditioned media alone (Fig. 1a and b; n = 3; P < 0.05,
one-way ANOVA), compared to thiorphan conﬁrming the
presence of ECE-1.
To determine if shedding of ECE-1 from the cell surface is
mediated by PKC, cells were incubated in the presence of
PMA (an activator of PKC), and media was tested for ECE-
1 activity. The presence of PMA in the media failed to have
any signiﬁcant eﬀect on the rate of ﬂuorescence (0.51 ±
0.02 U of ﬂuorescence/min; n = 3), compared to control condi-
tions (0.47 ± 0.03 U of ﬂuorescence/min; n = 3; one-way ANO-
VA) indicating that ECE-1 is only constitutively released. In
addition, ﬂuorescence induced by cell membrane proteins trea-
ted with PMA (4.96 ± 0.55 U of ﬂuorescence/min; n = 3) did
not diﬀer signiﬁcantly compared to that of control membrane
proteins (3.03 ± 0.91 U of ﬂuorescence/min; n = 3; one-way
ANOVA).
The role of metalloproteases in the shedding of ECE-1 from
cells, was examined by adding the broad spectrum metallopro-
tease inhibitor GM6001 to media. It resulted in a signiﬁcant
reduction in rate of ﬂuorescence, suggesting a possible role for
MMPs and ADAMs in the shedding of ECE-1 (Fig. 2; n = 3,
two-way ANOVA; P < 0.05). To further characterize the prote-
ases involved in ECE-1 shedding, the cells were incubated with
more speciﬁc inhibitors: TIMP-1, TIMP-3 (natural protease
inhibitors) and TAPI-1 (TACE inhibitor). Addition of TIMP-
1 and TIMP-3 had no signiﬁcant eﬀect on the rate of ﬂuores-
cence (data not shown), while TAPI-1 signiﬁcantly reduced
the rate of ﬂuorescence similar to GM 6001. The activity is sig-
niﬁcantly reduced when control media is tested in the presence
of thiorphan (Fig. 2; n = 3, two-way ANOVA; P < 0.05), indi-
cating the release of NEP as well into the media. However, no
signiﬁcant decrease in the rate of ﬂuorescence is observed when
media treated with GM6001 or TAPI-1 is tested for activity in
the presence of thiorphan, when compared to control media
tested in the presence of thiorphan.3.2. BigET and BigET18–34 assay and mass spectrometry
The reaction mixture containing BigET18–34 (MW 1907 Da)
and conditioned media alone, as well as in the presence of
inhibitors thiorphan/phosphoramidon was analysed by MAL-
DI-ToF at the indicated time points. All MALDI spectra at
time = 0 min conﬁrmed the presence of BigET18–34, but neither
the C-terminal cleavage product BigET22–34 (MW 1380 Da),
nor the N-terminal cleavage product BigET18–21 (MW
545 Da) were detected (data not shown). BigET22–34 was
detected in the mixture containing media alone, and in the
presence of thiorphan after 2 and 5 h, respectively (Fig. 3a
and b). Five hours of incubation failed to detect this product
in the reaction mixture containing media and phosphoramidon
(Fig. 3c). BigET18–21 was not detected in any of the MALDI
spectra generated.
The reaction mixture containing BigET and conditioned
media alone, as well as in the presence of inhibitors
thiorphan/phosphoramidon was also analysed by MALDI-
ToF at time = 0, 1 and 5 h. Spectra at time = 0 conﬁrmed
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Fig. 1. The eﬀect of (a) membrane proteins or (b) conditioned media alone (from HUVECs) and in the presence of thiorphan or phosphoramidon on
the cleavage of QFS. *Signiﬁcantly diﬀerent from conditioned media in the presence of thiorphan; n = 3, one-way ANOVA.
Control media GM 6001 TAPI-1
0.0
0.2
0.4
0.6
 Media alone
+ Thiorphan
+ Phosphoramidon
*
*
*
Un
its
 F
lu
or
es
ce
nc
e/
m
in
Fig. 2. The eﬀect of metalloproteinase inhibitors, GM6001 and TAPI-1 on the cleavage of QFS by conditioned media (from HUVEC) alone and in
the presence of thiorphan or phosphoramidon. *Signiﬁcantly diﬀerent to control media alone; two-way ANOVA; n = 3.
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minal cleavage product (BigET22–38; MW 1808) was not de-
tected (Fig. 4a). BigET22–38 was detected 1 h after incubation
with media alone (Fig. 4b). However, the presence of phospho-
ramidon in the reaction mixture appeared to signiﬁcantly re-
duce the rate of BigET cleavage. This is indicated by the
reduced intensity of the signal corresponding to BigET22–38
(Fig. 4c). In parallel experiments cleavage of BigET was exam-
ined in the presence of the NEP inhibitor thiorphan, where
cleavage was comparable to that observed under control con-
ditions (data not shown).3.3. Nano-LC MSMS analysis
Following reverse phase separation of the reaction mixture
consisting of BigET18–34 and conditioned media, the fractions
containing BigET18–34 and BigET22–34 (m/z 1380) was analysed
by tandem mass spectrometry. The amino acid sequence of the
resulting peptide fragments and their corresponding molecular
masses are listed in Tables 1 and 2. In addition to the m/z ratio
obtained by mass spectrometry, the results of tandem
mass spectrometry analysis provides further proof for cleavage
of BigET18–34 by conditioned media between Trp
21 and
Val22.
Fig. 3. MALDI-ToF analysis of the reaction mixture containing
BigET18–34 and (a) conditioned media alone after 2 h, conditioned
media in the presence of (b) thiorphan or (c) phosphoramidon after
5 h. a: BigET22–34; b: BigET18–34.
Fig. 4. MALDI-ToF analysis of the reaction mixture containing
BigET and conditioned media only at (a) time = 0, (b) 1 h and (c) in
the presence of phosphoramidon at 1 h.
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Ectodomain shedding has emerged as an important mecha-
nism which regulates the functions of various integral mem-
brane proteins which include, adhesion molecules, cytokines,
growth factors and their receptors [17–19]. Human umbilical
vein endothelial cells are known to release endothelins [20]
and endogenously express ECE-1 [21]. Therefore, these cells
were chosen to study the mechanisms behind the shedding of
the catalytically active ectodomain of ECE-1. However, the
co-expression of closely related NEP enzyme by HUVECs
added a degree of complication to the study, requiring the as-
says to be conducted in the presence of speciﬁc NEP inhibitor
thiorphan. The NEP homologue NEP-2, has high sequence
identity with NEP and is known to be localized only in thecentral nervous system and testis, in this context, phosphora-
midon is more eﬀective than thiorphan in inhibiting NEP-2
[22].
The conditioned media and cell membrane preparations
were initially assayed for ECE-1 activity based on their ability
to cleave QFS. The amino acid sequence of QFS used in this
study is based on that of bradykinin, another known substrate
for ECE-1 [3,23]. Despite it also being a substrate for NEP,
QFS is hydrolysed 10-fold more eﬃciently by ECE-1 (Kcat/
Km value 1.9 · 107 M1 S1 [16]) making this substrate more
selective for ECE-1. The amount of NEP in the conditioned
media and membrane preparations, as evidenced by the re-
Table 1
Peptide fragments of BigET18–34(MW 1907 Da)
Actual mass (Da) as
conﬁrmed by MSMS
Mass (Da) calculated based on
amino acid sequence
Predicted amino acid
sequence
Amino acid sequence
conﬁrmed by MSMS
364 381 PEH PEH
562 579 PEHVV; EHVVP PEHVV; EHVVP
564 581 TPEHV TPEHV
840 857 IWVNTPE IWVNTPE
1066 1112 NTPEHVVPYG NTPEHVVPYG
1288 1306 IIWVNTPEHVV IIWVNTPEHVV
1379 1397 WVNTPEHVVPYG WVNTPEHVVPYG
1407 1435 IWVNTPEHVVPY IWVNTPEHVVPY
Table 2
Peptide fragments of BigET22–34(MW 1380 Da)
Actual mass (Da) as
conﬁrmed by MSMS
Mass (Da) calculated based on
amino acid sequence
Predicted sequence Sequence conﬁrmed
by MSMS
336 353 HVV HVV
381 364 PEH PEH
678 695 NTPEHV NTPEHV
777 794 NTPEHVV NTPEHVV
874 891 NTPEHVVP NTPEHVVP
1066 1112 NTPEHVVPYG NTPEHVVPYG
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considerably amongst cell passages. However, the presence of
ECE-1 was always conﬁrmed upon addition of phosphorami-
don, a dual ECE-1 and NEP inhibitor which signiﬁcantly
reduced the rate of ﬂuorescence compared to thiorphan.
It has been widely reported that various cell surface proteins
are shed upon stimulation by PMA which activates PKC, thus
triggering a metalloproteinase dependent ectodomain shedding
machinery [24,25]. This pathway is described as ‘inducible
shedding’ and is known to be highly conserved amongst
multiple cell types [17]. The results of this study indicated that
ECE-1 is only released constitutively and that PMA has no
eﬀect on the shedding process. Although previous studies indi-
cate that ECE-1 migrates to the cell surface upon stimulation
by PMA [26], this was not conﬁrmed by the results of this
study.
Members of the metalloproteinase super family have been
shown to be responsible for the cleavage of a majority of shed
proteins [27]. Therefore, to determine the involvement of these
proteins in the cleavage of ECE-1, a broad spectrum metallo-
proteinase inhibitor GM6001 was added to the cells. Identiﬁca-
tion of the speciﬁc metalloproteinase responsible for ECE-1
shedding was undertaken based on reports that ADAM-10
and ADAM-17/TACE, have been implicated in the constitu-
tive and PMA induced shedding of a number of cell surface ex-
pressed molecules [17,27,28]. Most MMPs are blocked by the
TIMPs 1, 2 and 3, whereas ADAM-10 is inhibited by TIMP-
1 and TACE activity is sensitive to TAPI-1 and TIMP-3 [29–
31]. Results of experiments using TIMP-1 and TIMP-3 ruled
out MMP and ADAM-10, mediated shedding of ECE-1.
TAPI-1 reduced the rate of ﬂuorescence to a level similar to
that observed in the presence of GM6001 suggesting a role
for TACE in the shedding process. Although a decrease in
the rate of ﬂuorescence in response to TIMP-3 (a known
TACE inhibitor) was expected, this was not observed. How-
ever, the lack of a signiﬁcant diﬀerence in the ﬂuorescence in-duced by media treated with GM6001/TAPI-1 (+thiorphan),
compared to control media (+thiorphan) indicates that the
inhibitors blocked NEP release as opposed to ECE-1 release.
Since neither inhibitor completely abrogated NEP or ECE-1
release, another mechanism(s) may regulate their release. Such
mechanisms have been postulated in relation to the release of
other membrane proteins such as Axl [17].
Since the QFS used in this study can also be cleaved by NEP,
we obtained further proof for the presence of ECE-1 in the
media by using ECE-1 speciﬁc natural substrate BigET18–34,
which is known to undergo 60% cleavage by ECE-1 [32].
Analysis by liquid chromatography indicated the cleavage of
BigET18–34 by cell membrane preparations as well as condi-
tioned media, as evidenced by a decreasing substrate peak area
with increasing time. However, the cleavage products appeared
to undergo secondary degradation, and were below the level of
detection by liquid chromatography. Therefore, we undertook
a mass spectrometry approach to determine the identity of the
ECE-1 mediated cleavage products of BigET18–34. The ex-
pected ECE-1 mediated C-terminal cleavage product was con-
ﬁrmed by mass as well as sequence, and further, it was
inhibited by phosphoramidon but not thiorphan. This there-
fore clearly demonstrates the presence of ECE-1 in the condi-
tioned media. Additional evidence was obtained by examining
the cleavage of the natural substrate BigET as well by condi-
tioned media. As observed with BigET18–34, only the C-termi-
nal cleavage product BigET22–38 was observed. The cleavage of
BigET was inhibited by phosphoramidon and not thiorphan,
thus given that cleavage of BigET at this site is highly ECE
speciﬁc, these data conﬁrm ECE-1 mediated cleavage.
It is not known whether the surface of HUVECs express
NEP-2. A comparison of the catalytic activities and substrate
speciﬁcities of NEP and NEP-2 has been undertaken by Rose
et al. [33]. The results presented would strongly suggest that
NEP-2 is unlikely to be involved in the cleavage of the sub-
strates used in our study, particularly in the face of the high
4506 S. Kuruppu et al. / FEBS Letters 581 (2007) 4501–4506concentration of thiorphan used (100 lM) and the very much
greater cleavage eﬃciency of bradykinin by NEP compared to
NEP-2.
In conclusion, HUVECs endogenously express ECE-1 as
well as NEP. Our results demonstrate for the ﬁrst time that
ECE-1 is shed from the surface of HUVECs via MMP or
ADAM independent pathway, and is not stimulated by the
activation of PKC. The release of NEP occurs to a lesser ex-
tent, and appears to be mediated by TACE. The results of this
study highlight the potential for the use of circulating ECE-1
as a diagnostic or prognostic marker of pathological condi-
tions such as cardiovascular diseases.References
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